Biomanufacturing Viral Detection and Quantification Market Forecast to 2032

Market Research Report

A quick peek into the report

1.1 Inclusion and Exclusion Criteria

2.1 Scope of the Study
2.2 Key Questions Answered in the Report

Research Methodology

4.1 Overview
4.2 Current Market Size and Future Growth Potential, $Billion, 2022-2032

5.1   Regulatory Landscape
5.1.1   Legal Requirements and Frameworks in the U.S.
5.1.1.1   Marketing Authorization
5.1.2   Legal Requirements and Frameworks in Europe
5.1.3   Legal Requirements and Frameworks in Asia-Pacific
5.1.3.1   Legal Requirements and Framework in Japan

6.1   Business Drivers
6.1.1   Increasing Utilization of Biopharmaceuticals
6.1.2   Technological Advancements in Viral Detection and Quantification
6.1.3   Impact Analysis
6.2   Business Restraints
6.2.1   High Cost of Advanced Viral Detection and Quantification Equipment
6.2.2   Lack of Trained Professionals in the Field of Viral Detection and Quantification
6.2.3   Impact Analysis
6.3   Business Opportunities
6.3.1   Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

7.1   Overview
7.2   Consumables
7.2.1   Kits and Assays
7.2.2   Accessories
7.3   Instruments
7.4   Services

8.1   Overview
8.2   PCR
8.3   Flow Cytometry
8.4   ELISA
8.5   Plaque Assay
8.6   Others

9.1   Overview
9.2   Blood and Blood Products Manufacturing
9.3   Cellular and Gene Therapy Products Manufacturing
9.4   Stem Cell Products Manufacturing
9.5   Tissue and Tissue Products Manufacturing
9.6   Vaccines and Therapeutics Manufacturing

10.1   Overview
10.2   Life Science Companies
10.3   Testing Laboratories
10.4   CROs and CDMOs

11.1   Overview
11.2   North America
11.2.1   North America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.2.2   North America Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.2.3   North America Biomanufacturing Viral Detection and Quantification Market (by Application)
11.2.4   North America Biomanufacturing Viral Detection and Quantification Market (by End User)
11.2.5   North America Biomanufacturing Viral Detection and Quantification Market (by Country)
11.2.5.1   U.S.
11.2.5.1.1   U.S. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.2.5.1.2   U.S. Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.2.5.1.3   U.S. Biomanufacturing Viral Detection and Quantification Market (by Application)
11.2.5.1.4   U.S. Biomanufacturing Viral Detection and Quantification Market (by End User)
11.2.5.2   Canada
11.2.5.2.1   Canada Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.2.5.2.2   Canada Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.2.5.2.3   Canada Biomanufacturing Viral Detection and Quantification Market (by Application)
11.2.5.2.4   Canada Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3   Europe
11.3.1   Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.3.2   Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.3.3   Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
11.3.4   Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3.5   Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
11.3.5.1   Germany
11.3.5.1.1   Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.3.5.1.2   Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.3.5.1.3   Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
11.3.5.1.4   Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3.5.2   U.K.
11.3.5.2.1   U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.3.5.2.2   U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.3.5.2.3   U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
11.3.5.2.4   U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3.5.3   France
11.3.5.3.1   France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.3.5.3.2   France Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.3.5.3.3   France Biomanufacturing Viral Detection and Quantification Market (by Application)
11.3.5.3.4   France Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3.5.4   Spain
11.3.5.4.1   Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.3.5.4.2   Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.3.5.4.3   Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
11.3.5.4.4   Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3.5.5   Italy
11.3.5.5.1   Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.3.5.5.2   Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.3.5.5.3   Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
11.3.5.5.4   Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3.5.6   Rest-of-Europe
11.3.5.6.1   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.3.5.6.2   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.3.5.6.3   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
11.3.5.6.4   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4   Asia-Pacific
11.4.1   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.4.2   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.4.3   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
11.4.4   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4.5   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
11.4.5.1   China
11.4.5.1.1   China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.4.5.1.2   China Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.4.5.1.3   China Biomanufacturing Viral Detection and Quantification Market (by Application)
11.4.5.1.4   China Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4.5.2   Japan
11.4.5.2.1   Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.4.5.2.2   Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.4.5.2.3   Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
11.4.5.2.4   Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4.5.3   India
11.4.5.3.1   India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.4.5.3.2   India Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.4.5.3.3   India Biomanufacturing Viral Detection and Quantification Market (by Application)
11.4.5.3.4   India Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4.5.4   Australia
11.4.5.4.1   Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.4.5.4.2   Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.4.5.4.3   Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
11.4.5.4.4   Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4.5.5   South Korea
11.4.5.5.1   South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.4.5.5.2   South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.4.5.5.3   South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
11.4.5.5.4   South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4.5.6   Rest-of-Asia-Pacific
11.4.5.6.1   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.4.5.6.2   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.4.5.6.3   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
11.4.5.6.4   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
11.5   Latin America
11.5.1   Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.5.2   Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.5.3   Latin America Biomanufacturing Viral Detection and Quantification Market (by Application)
11.5.4   Latin America Biomanufacturing Viral Detection and Quantification Market (by End User)
11.5.4.1   Brazil
11.5.4.1.1   Brazil Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.5.4.1.2   Brazil Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.5.4.1.3   Brazil Biomanufacturing Viral Detection and Quantification Market (by Application)
11.5.4.1.4   Brazil Biomanufacturing Viral Detection and Quantification Market (by End User)
11.5.4.2   Mexico
11.5.4.2.1   Mexico Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.5.4.2.2   Mexico Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.5.4.2.3   Mexico Biomanufacturing Viral Detection and Quantification Market (by Application)
11.5.4.2.4   Mexico Biomanufacturing Viral Detection and Quantification Market (by End User)
11.5.4.3   Rest-of-Latin America
11.5.4.3.1   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.5.4.3.2   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.5.4.3.3   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Application)
11.5.4.3.4   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by End User)
11.6   Middle East and Africa
11.6.1   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.6.2   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.6.3   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
11.6.4   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User)
11.6.4.1   South Africa
11.6.4.1.1   South Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.6.4.1.2   South Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.6.4.1.3   South Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
11.6.4.1.4   South Africa Biomanufacturing Viral Detection and Quantification Market (by End User)
11.6.4.2   Israel
11.6.4.2.1   Israel Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.6.4.2.2   Israel Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.6.4.2.3   Israel Biomanufacturing Viral Detection and Quantification Market (by Application)
11.6.4.2.4   Israel Biomanufacturing Viral Detection and Quantification Market (by End User)
11.6.4.3   U.A.E.
11.6.4.3.1   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.6.4.3.2   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.6.4.3.3   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Application)
11.6.4.3.4   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by End User)
11.6.4.4   Saudi Arabia
11.6.4.4.1   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.6.4.4.2   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.6.4.4.3   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Application)
11.6.4.4.4   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by End User)
11.6.4.5   Rest-of-Middle East and Africa
11.6.4.5.1   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
11.6.4.5.2   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
11.6.4.5.3   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
11.6.4.5.4   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User)

12.1   Overview
12.2   Company Share Analysis
12.3   Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
12.4   Danaher Corporation
12.4.1   Company Overview
12.4.2   Role of Danaher Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
12.4.3   Key Competitors
12.4.4   Financials
12.4.5   Key Insights about the Financial Health of the Company
12.4.6   Analyst Perspective
12.5   Merck KGaA
12.5.1   Company Overview
12.5.2   Role of Merck KGaA in the Global Biomanufacturing Viral Detection and Quantification Market
12.5.3   Key Competitors
12.5.4   Financials
12.5.5   Key Insights about the Financial Health of the Company
12.5.6   Analyst Perspective
12.6   New England Biolabs
12.6.1   Company Overview
12.6.2   Role of New England Biolabs in the Global Biomanufacturing Viral Detection and Quantification Market
12.6.3   Key Competitors
12.6.4   Analyst Perspective
12.7   TAKARA HOLDINGS INC.
12.7.1   Company Overview
12.7.2   Role of TAKARA HOLDINGS INC. in the Global Biomanufacturing Viral Detection and Quantification Market
12.7.3   Key Competitors
12.7.4   Financials
12.7.5   Key Insights about the Financial Health of the Company
12.7.6   Analyst Perspective
12.8   Thermo Fisher Scientific Inc.
12.8.1   Company Overview
12.8.2   Role of Thermo Fisher Scientific Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
12.8.3   Key Competitors
12.8.4   Financials
12.8.5   Key Insights about the Financial Health of the Company
12.8.6   Analyst Perspective
12.9   Agilent Technologies, Inc.
12.9.1   Company Overview
12.9.2   Role of Agilent Technologies, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
12.9.3   Key Competitors
12.9.4   Financials
12.9.5   Key Insights about the Financial Health of the Company
12.9.6   Analyst Perspective
12.10 Sartorius AG
12.10.1   Company Overview
12.10.2   Role of Sartorius AG in the Global Biomanufacturing Viral Detection and Quantification Market
12.10.3   Key Competitors
12.10.4   Financials
12.10.5   Analyst Perspective
12.11   Charles River Laboratories
12.11.1   Company Overview
12.11.2   Role of Charles River Laboratories in the Global Biomanufacturing Viral Detection and Quantification Market
12.11.3   Key Competitors
12.11.4   Financials
12.11.5   Analyst Perspective
12.12   Bio-Rad Laboratories, Inc.
12.12.1   Company Overview
12.12.2   Role of Bio-Rad Laboratories, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
12.12.3   Key Competitors
12.12.4   Financials
12.12.5   Key Insights about the Financial Health of the Company
12.12.6   Analyst Perspective
12.13   PerkinElmer, Inc.
12.13.1   Company Overview
12.13.2   Role of PerkinElmer, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
12.13.1   Key Competitors
12.13.2   Financials
12.13.3   Key Insights about the Financial Health of the Company
12.13.4   Analyst Perspective
12.14   Promega Corporation
12.14.1   Company Overview
12.14.2   Role of Promega Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
12.14.3   Key Competitors
12.14.4   Analyst Perspective
12.15   QIAGEN N.V.
12.15.1   Company Overview
12.15.2   Role of QIAGEN N.V. in the Global Biomanufacturing Viral Detection and Quantification Market
12.15.3   Key Competitors
12.15.4   Financials
12.15.5   Key Insights about the Financial Health of the Company
12.15.6   Analyst Perspective
12.16   Genscript Biotech Corporation
12.16.1   Company Overview
12.16.2   Role of Genscript Biotech Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
12.16.3   Key Competitors
12.16.4   Financials
12.16.5   Key Insights about the Financial Health of the Company
12.16.6   Analyst Perspective
12.17   Norgen Biotek Corp.
12.17.1   Company Overview
12.17.2   Role of Norgen Biotek Corp. in the Global Biomanufacturing Viral Detection and Quantification Market
12.17.3   Key Competitors
12.17.4   Analyst Perspective

Table 1:   Global Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
Table 2:   Key Questions Answered in the Report
Table 3:   Methods of Virus Detection and Quantification
Table 4:   Biomanufacturing Viral Detection and Quantification Market: Global Regulatory Scenario
Table 5:   Technological Advancement in the Field of Viral Testing
Table 6:   Impact Analysis: Business Drivers
Table 7:   Impact Analysis: Business Restraints

Figure 1:   Global Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 2:   Global Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
Figure 3:   Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
Figure 4:   Global Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
Figure 5:   Global Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
Figure 6:   Global Biomanufacturing Viral Detection and Quantification Market (by Region), $Billion, 2022 and 2032
Figure 7:   Global Biomanufacturing Viral Detection and Quantification Market Segmentation
Figure 8:   Global Biomanufacturing Viral Detection and Quantification Market: Research Methodology
Figure 9:   Primary Research Methodology
Figure 10:   Bottom-Up Approach (Segment-Wise Analysis)
Figure 11:   Top-Down Approach (Segment-Wise Analysis)
Figure 12:   Global Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 13:   Steps Involved in FDA Regulation
Figure 14:   Steps for Obtaining Marketing Authorization
Figure 15:   Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
Figure 16:   Global Biomanufacturing Viral Detection and Quantification Market (Consumables), $Billion, 2022-2032
Figure 17:   Global Biomanufacturing Viral Detection and Quantification Market (Kits and Assays), $Billion, 2022-2032
Figure 18:   Global Biomanufacturing Viral Detection and Quantification Market (Accessories), $Billion, 2022-2032
Figure 19:   Global Biomanufacturing Viral Detection and Quantification Market (Instruments), $Billion, 2022-2032
Figure 20:   Global Biomanufacturing Viral Detection and Quantification Market (Services), $Billion, 2022-2032
Figure 21:   Global Biomanufacturing Viral Detection and Quantification Market (by Technology)
Figure 22:   Steps Involved in PCR for Viral Detection and Quantification
Figure 23:   Global Biomanufacturing Viral Detection and Quantification Market (PCR), $Billion, 2022-2032
Figure 24:   Steps Involved in Flow Cytometry for Viral Detection and Quantification
Figure 25:   Global Biomanufacturing Viral Detection and Quantification Market (Flow Cytometry), $Billion, 2022-2032
Figure 26:   Steps Involved in ELISA for Viral Detection and Quantification
Figure 27:   Global Biomanufacturing Viral Detection and Quantification Market (ELISA), $Billion, 2022-2032
Figure 28:   Global Biomanufacturing Viral Detection and Quantification Market (Plaque Assay), $Billion, 2022-2032
Figure 29:   Global Biomanufacturing Viral Detection and Quantification Market (Others), $Billion, 2022-2032
Figure 30:   Global Biomanufacturing Viral Detection and Quantification Market (by Application)
Figure 31:   Global Biomanufacturing Viral Detection and Quantification Market (Blood and Blood Products Manufacturing), $Billion, 2022-2032
Figure 32:   Global Biomanufacturing Viral Detection and Quantification Market (Cellular and Gene Therapy Products Manufacturing), $Billion, 2022-2032
Figure 33:   Global Biomanufacturing Viral Detection and Quantification Market (Stem Cell Products Manufacturing), $Billion, 2022-2032
Figure 34:   Global Biomanufacturing Viral Detection and Quantification Market (Tissue and Tissue Products Manufacturing), $Billion, 2022-2032
Figure 35:   Global Biomanufacturing Viral Detection and Quantification Market (Vaccines and Therapeutics Manufacturing), $Billion, 2022-2032
Figure 36:   Global Biomanufacturing Viral Detection and Quantification Market (by End User)
Figure 37:   Global Biomanufacturing Viral Detection and Quantification Market (Life Science Companies), $Billion, 2022-2032
Figure 38:   Use of Viral Detection and Quantification in Testing Laboratories
Figure 39:   Global Biomanufacturing Viral Detection and Quantification Market (Testing Laboratories) $Billion, 2022-2032
Figure 40:   Global Biomanufacturing Viral Detection and Quantification Market (CROs and CDMOs) $Billion, 2022-2032
Figure 41:   Global Biomanufacturing Viral Detection and Quantification Market (by Region)
Figure 42:   North America: Market Dynamics
Figure 43:   North America Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 44:   North America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 45:   North America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 46:   North America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 47:   North America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 48:   U.S. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 49:   U.S. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 50:   U.S. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 51:   U.S. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 52:   U.S. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 53:   Canada Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 54:   Canada Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 55:   Canada Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 56:   Canada Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 57:   Canada Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 58:   Europe: Market Dynamics
Figure 59:   Europe Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 60:   Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 61:   Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 62:   Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 63:   Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 64:   Germany Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 65:   Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 66:   Germany Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 67:   Germany Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 68:   Germany Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 69:   U.K. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 70:   U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 71:   U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 72:   U.K. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 73:   U.K. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 74:   France Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 75:   France Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 76:   France Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 77:   France Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 78:   France Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 79:   Spain Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 80:   Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 81:   Spain Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 82:   Spain Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 83:   Spain Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 84:   Italy Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 85:   Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 86:   Italy Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 87:   Italy Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 88:   Italy Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 89:   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 90:   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 91:   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 92:   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 93:   Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 94:   Measures Undertaken by APAC to Enhance its Viral Testing Capacity
Figure 95:   Asia-Pacific: Market Dynamics
Figure 96:   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 97:   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 98:   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 99:   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 100:   Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 101:   China Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 102:   China Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 103:   China Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 104:   China Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 105:   China Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 106:   Japan Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 107:   Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 108:   Japan Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 109:   Japan Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 110:   Japan Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 111:   India Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 112:   India Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 113:   India Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 114:   India Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 115:   India Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 116:   Australia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 117:   Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 118:   Australia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 119:   Australia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 120:   Australia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 121:   South Korea Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 122:   South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 123:   South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 124:   South Korea Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 125:   South Korea Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 126:   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 127:   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 128:   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 129:   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 130:   Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 131:   Latin America: Market Dynamics
Figure 132:   Latin America Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 133:   Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 134:   Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 135:   Latin America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 136:   Latin America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 137:   Brazil Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 138:   Brazil Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 139:   Brazil Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 140:   Brazil Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 141:   Brazil Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 142:   Mexico Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 143:   Mexico Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 144:   Mexico Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 145:   Mexico Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 146:   Mexico Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 147:   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 148:   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 149:   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 150:   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 151:   Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 152:   Middle East and Africa: Market Dynamics
Figure 153:   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 154:   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 155:   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 156:   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 157:   Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 158:   South Africa Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 159:   South Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 160:   South Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 161:   South Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 162:   South Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 163:   Israel Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 164:   Israel Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 165:   Israel Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 166:   Israel Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 167:   Israel Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 168:   U.A.E. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 169:   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 170:   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 171:   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 172:   U.A.E. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 173:   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 174:   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 175:   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 176:   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 177:   Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 178:   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 179:   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 180:   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 181:   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 182:   Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 183:   Global Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
Figure 184:   Global Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
Figure 185:   Danaher Corporation: Product Portfolio
Figure 186:   Danaher Corporation: Overall Financials, $Million, 2020-2022
Figure 187:   Danaher Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 188:   Danaher Corporation: Revenue (by Region), $Million, 2020-2022
Figure 189:   Danaher Corporation: R&D Expenditure, $Million, 2020-2022
Figure 190:   Merck KGaA: Product Portfolio
Figure 191:   Merck KGaA: Overall Financials, $Million, 2020-2022
Figure 192:   Merck KGaA: Revenue (by Segment), $Million, 2020-2022
Figure 193:   Merck KGaA: Revenue (by Region), $Million, 2020-2022
Figure 194:   Merck KGaA: R&D Expenditure, $Million, 2020-2022
Figure 195:   New England Biolabs: Product Portfolio
Figure 196:   TAKARA HOLDINGS INC.: Product Portfolio
Figure 197:   TAKARA HOLDINGS INC.: Overall Financials, $Million, 2020-2022
Figure 198:   TAKARA HOLDINGS INC.: Revenue (by Region), $Million, 2020-2022
Figure 199:   TAKARA HOLDINGS INC.: R&D Expenditure, $Million, 2020-2022
Figure 200:   Thermo Fisher Scientific Inc.: Product Portfolio
Figure 201:   Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
Figure 202:   Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 203:   Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
Figure 204:   Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022
Figure 205:   Agilent Technologies, Inc.: Product Portfolio
Figure 206:   Agilent Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 207:   Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 208:   Agilent Technologies, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 209:   Agilent Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 210:   Sartorius AG: Product Portfolio
Figure 211:   Sartorius AG: Overall Financials, $Million, 2020-2022
Figure 212:   Sartorius AG: Revenue (by Segment), $Million, 2020-2022
Figure 213:   Sartorius AG: Revenue (by Region), $Million, 2020-2022
Figure 214:   Charles River Laboratories: Product Portfolio
Figure 215:   Charles River Laboratories: Overall Financials, $Million, 2020-2022
Figure 216:   Charles River Laboratories: Revenue (by Segment), $Million, 2020-2022
Figure 217:   Charles River Laboratories: Revenue (by Region), $Million, 2020-2022
Figure 218:   Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 219:   Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2020-2022
Figure 220:   Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 221:   Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 222:   Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 223:   PerkinElmer, Inc.: Product Portfolio
Figure 224:   PerkinElmer, Inc.: Overall Financials, $Million, 2021-2023
Figure 225:   PerkinElmer, Inc.: Revenue (by Segment), $Million, 2021-2023
Figure 226:   PerkinElmer, Inc.: Revenue (by Region), $Million, 2021-2023
Figure 227:   PerkinElmer, Inc.: R&D Expenditure, $Million, 2021-2023
Figure 228:   Promega Corporation: Product Portfolio
Figure 229:   QIAGEN N.V.: Product Portfolio
Figure 230:   QIAGEN N.V.: Overall Financials, $Million, 2020-2022
Figure 231:   QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
Figure 232:   QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
Figure 233:   QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
Figure 234:   Genscript Biotech Corporation: Product Portfolio
Figure 235:   Genscript Biotech Corporation: Overall Financials, $Million, 2020-2022
Figure 236:   Genscript Biotech Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 237:   Genscript Biotech Corporation: Revenue (by Region), $Million, 2020-2022
Figure 238:   Genscript Biotech Corporation: R&D Expenditure, $Million, 2020-2022
Figure 239:   Norgen Biotek Corp.: Product Portfolio

Market Report Coverage

Source: BIS Research Analysis

Key Market Players and Competition Synopsis

Viral contamination poses a significant risk to both animal- and human-derived biopharmaceuticals. This form of contamination can occur at any stage of the bioproduction process, necessitating viral testing studies and the implementation of viral clearance methods by biomanufacturers. In this study, several types of fundamental technologies have been examined that have facilitated these advances, namely, polymerase chain reaction (PCR), plaque assays, flow cytometry, and enzyme-linked immunosorbent assay (ELISA), among others. The global biomanufacturing viral detection and quantification market is strongly driven by the continuous introduction of new technologies as well as increased investments and funding from both the government and private sectors.

Key Companies Profiled:

•   Danaher Corporation
•   Merck KGaA
•   New England Biolabs
•   TAKARA HOLDINGS INC.
•   Thermo Fisher Scientific Inc.
•   Agilent Technologies, Inc.
•   Sartorius AG
•   Charles River Laboratories
•   Bio-Rad Laboratories, Inc.
•   PerkinElmer, Inc.
•   Promega Corporation
•   QIAGEN N.V.
•   Genscript Biotech Corporation
•   Norgen Biotek Corp.

How can this report add value to an organization?

Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the global biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the global biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Industry and Technology Overview

Global Biomanufacturing Viral Detection and Quantification Market Industry Overview

Source: BIS Research Analysis

The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032. The global biomanufacturing viral detection and quantification market is expected to be driven by the rising utilization of biopharmaceutical products and the technological advancements in the viral testing industry.

Market Lifecycle Stage

The global biomanufacturing viral detection and quantification market is in progressing phase. The biomanufacturing viral detection and quantification market is experiencing rapid growth due to the increasing adoption of biopharmaceuticals. Robust quality control processes are essential to ensure the safety, efficacy, and consistency of biopharmaceuticals. These factors are expected to drive the demand for consumables and instruments for quantification of viral contaminants during biomanufacturing of biologics, thereby augmenting the growth of the biomanufacturing viral detection and quantification market.

Impact

Viral detection and quantification is used to evaluate and improve the biomanufacturing process throughout process development. Manufacturers can detect potential viral contamination sources and make the required adjustments to reduce risks and boost process effectiveness by detecting and quantifying viral contaminants at different stages. Emerging cell and gene therapies, along with other biotherapeutics, are at risk of contamination, including viral contaminants. Detecting these contaminants early on is important to prevent any delays in the production process, which can have a direct impact on the commercialization of therapy. Cell and gene therapies utilize viral vectors to deliver therapeutic genes or manipulate cells for therapeutic purposes. In addition, the entry of several established players, such as Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories, Bio-Rad Laboratories, Inc., QIAGEN N.V., and others, is expected to aid the market growth.

Due to better cleanliness, people witnessed global advancement in the control of infectious contamination over the past few years. The market for biomanufacturing viral detection and quantification is expanding due to the growing demand for precise viral testing in the biomanufacturing of therapies. In conclusion, as the field of emerging cell and gene therapies continues to advance, it is imperative to address the potential risks of viral contamination.

Market Segmentation:

Segmentation 1: by Offering Type
•   Consumables
•   Instruments
•   Services

Consumables Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type)

Based on offering type, the consumables segment dominated the global biomanufacturing viral detection and quantification market in FY2022. The increasing adoption of kits, assays, and accessories contributed to the prominence of the consumables segment. Consumables are products and materials that are constantly consumed throughout the viral testing process. Several consumables are utilized in viral detection and quantification during biomanufacturing to simplify testing and analysis of viral samples. These consumables are necessary to carry out the several procedures and tests required to determine the quantity or concentration of a particular virus in a biological sample.

Segmentation 2: by Technology
•   PCR
•   ELISA
•   Flow Cytometry
•   Plaque Assay
•   Others

PCR Technology Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Technology)

Based on technology, the PCR segment dominated the global biomanufacturing viral detection and quantification market in FY2022. In the field of molecular biology and viral testing, polymerase chain reaction (PCR) is a commonly used technique. It is a method for identifying and measuring viral nucleic acids that are sensitive and focused during the production of biopharmaceuticals. In addition, PCR is essential for measuring the viral load, or the quantity of viral genetic material, in a biological sample.

Segmentation 3: by Application
•   Blood and Blood Products Manufacturing
•   Vaccines and Therapeutics Manufacturing
•   Cellular and Gene Therapy Products Manufacturing
•   Stem Cell Products Manufacturing
•   Tissue and Tissue Products Manufacturing

Blood and Blood Products Manufacturing Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Application)

Based on application, the global biomanufacturing viral detection and quantification market was dominated by the blood and blood products manufacturing segment in FY2022. In biomanufacturing processes, viral testing is an essential component in verifying the safety and quality of blood and blood products. This test involves identifying and measuring viral particles or viral nucleic acids that are present in blood samples. To identify and measure viral nucleic acids, methods such as nucleic acid amplification testing (NAT) are often employed.

Segmentation 4: by End User
•   Life Science Companies
•   Testing Laboratories
•   CROs and CDMOs

Life Science Companies to Continue its Dominance in the End User Segment

Based on end user, the life science companies segment accounted for the largest share of the global biomanufacturing viral detection and qauntification market in FY2022. In the life science sector, viral detection and quantification refers to the measuring and evaluation of viral particles or viral components at distinct stages of medication development, production, and evaluation. Viral load, or the quantity or concentration of viruses present in each sample or system, must be detected and quantified.

Segmentation 6: by Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

North America held the largest share of 38.72% in 2022 in the global biomanufacturing viral detection and quantification market, owing to the presence of most key players and rising funding in the region.

In addition, Asia-Pacific is expected to grow at the highest CAGR of 10.47% in the forecast period 2023-2032, owing to the continuous research and development in the viral detection and quantification industry as well as the supportive regulatory landscape.

Demand - Drivers and Limitations

Market Demand Drivers:

• Increasing Utilization of Biopharmaceuticals
• Technological Advancements in Viral Detection and Quantification

Market Restraints:

• High Cost of Advanced Viral Detection and Quantification Equipment
• Lack of Trained Professionals in the Field of Viral Detection and Quantification

Market Opportunities:

• Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

Analyst View

According to Akash Mhaskar, Principal Analyst, BIS Research, “The global biomanufacturing viral detection and quantification market is experiencing rapid growth due to the increasing utilization of biopharmaceuticals. Robust quality control processes are essential to ensure the safety, efficacy, and consistency of biologics. The market is driven by the need for stringent QC measures throughout the manufacturing journey, advancements in testing technologies, and expanding regulatory frameworks. The global biomanufacturing viral detection and quantification market has witnessed a steady growth in the number of new entrants and investments in biopharmaceuticals, thereby driving a surge in demand for the products and services required in the manufacturing and QC of biologics. This trend is also expected to continue over the forecast period. Therefore, the impact of the aforementioned factors is expected to drive the global biomanufacturing viral detection and quantification market in the near future.”

Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis

Focus on Offering Type, Technology, Application, End User, and Region - Analysis and Forecast, 2023-2032

Get Free Sample

Schedule a Call

Some Faq's

Frequently Asked Questions

Biomanufacturing viral detection and quantification is the procedure of assessing and establishing the quantity or concentration of viruses within the context of large-scale production of biological materials like vaccines, therapeutic proteins, or viral vectors. This process plays an important role in biomanufacturing, particularly when viruses are used as the active components. It ensures the final product's uniformity, quality, and safety. The techniques employed for viral detection and quantification may vary depending on the particular virus being measured and the specific demands of the biomanufacturing process.

New technologies and methods are rapidly emerging to enhance the detection and quantification of viral contaminants, which is driving the market for biomanufacturing viral detection and quantification. Here are some prevalent patterns in the industry:

Increasing utilization of biopharmaceuticals: Pharmaceuticals that are derived from living organisms or contain elements of living organisms are referred to as biopharmaceuticals, often known as biologics. Biopharmaceuticals are manufactured using biotechnological methods such as recombinant DNA technology, cell culture techniques, or other biologically based approaches, in contrast to traditional pharmaceutical medications, which are often chemically synthesized. The safety and quality of biopharmaceutical products are ensured through viral detection and quantification, which is essential to biopharmaceutical companies.

Technological advancements in viral detection and quantification: The development of testing methods such as polymerase chain reaction (PCR) and real-time PCR (qPCR) allows for the rapid and precise detection of viral infections by allowing the measurement of viral nucleic acids with great accuracy and sensitivity. From the perspective of large-scale identification, the utilization of real-time PCR and genome sequencing methods is impractical due to the costly laboratory infrastructure and the need for highly skilled personnel for sample processing and analysis. Advanced and effective viral detection is being made possible by innovative nanophotonic biosensors and RADICA technologies.

These are only a few illustrations of the major developments in the industry for biomanufacturing viral detection and quantifcation. Emerging innovations and technologies are anticipated to emerge as the area develops further, helping to influence the industry's future.

A new entrant can focus on various viral detection and quantification product offerings by established players. The market is fragmented with established market leaders such as Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc., who have had their presence in the market for the past many years. The new entrants can focus on their strategy of product launches and global expansions for biomanufacturing viral detection and quantification.

•   Detailed segmentation is delivered.
•   Region and country-level data based on market segmentation by offering type, technology, application, and end user type are provided.
•   Exhaustive product mapping for 25 companies is included.
•   Market share analysis (by company) is provided.
•   Viral detection and quantification ecosystem active player is provided.

•   Companies that manufacture and commercialize consumables and equipment required in the detection and quantification of viral contaminants during biopharmaceutical production
•   Any new entrant that wants to know where the opportunities lie in the biomanufacturing viral detection and quantification market
•   Any established player that wants to expand its product portfolio or business in new geographies

Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis : Focus on Therapy T

The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022...

View Report

A quick peek into the report

Table of Contents

Market Report Coverage

How can this report add value to an organization?

Industry and Technology Overview

$5500

Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis

Frequently Asked Questions

You may also like

Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis : Focus on Therapy T

Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis

A quick peek into the report

Table of Contents

1 Product Definition

2 Market Scope

3 Research Methodology

4 Market Overview

5 Industry Outlook

6 Global Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

7 Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type), Value ($Million), 2022-2032

8 Global Biomanufacturing Viral Detection and Quantification Market (by Technology), Value ($Million), 2022-2032

9 Global Biomanufacturing Viral Detection and Quantification Market (by Application), Value ($Million), 2022-2032

10 Global Biomanufacturing Viral Detection and Quantification Market (by End User), Value ($Million), 2022-2032

11 Global Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

12 Markets - Competitive Benchmarking & Company Profiles

List of Tables

List of Figures

Market Report Coverage

How can this report add value to an organization?

Industry and Technology Overview

$5500

Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis

Frequently Asked Questions

Q: What is biomanufacturing viral detection and quantification?

Q: What are the key trends in the biomanufacturing viral detection and quantification market?

Q: For a new company looking to enter the global biomanufacturing viral detection and quantification market, which areas could it focus on to stay ahead of the competition?

Q: What is the USP of this report?

Q: Who should buy this report?

You may also like

Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis : Focus on Therapy T